Loading...

MedXY AI/MedXY News/Tag: heart failure

MedXY News

EnglishTag

heart failure

147 all articles · 20 / page

Ask MedXY AI

clinical trial type 2 diabetes heart failure immunotherapy obesity atrial fibrillation Cardiology oncology cardiovascular risk biomarkers clinical trials public health Hypertension critical care breast cancer artificial intelligence Alzheimer's disease diabetes nutrition chronic kidney disease cardiovascular disease Pediatrics

Latest news

Tag

Elevated Heart Failure Risk in People With HIV: Insights from the REPRIEVE Trial

Elevated Heart Failure Risk in People With HIV: Insights from the REPRIEVE Trial

The REPRIEVE trial reveals higher heart failure incidence in people with HIV, particularly among women, Black participants in high-income regions, and those with hypertension or obesity. Traditional risk factors, not HIV-specific markers, w

Section: CardiologyMay 1, 2026

Exploring the Link Between Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure Risk in Older Adults

Exploring the Link Between Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure Risk in Older Adults

Higher CKM syndrome stages correlate with adverse cardiac remodeling and increased heart failure risk in older adults, as shown in the ARIC Study.

Section: Cardiology

Apr 29, 2026

Global Disparities in Heart Failure: Incidence and Mortality Across Income Levels and Regions

Global Disparities in Heart Failure: Incidence and Mortality Across Income Levels and Regions

The PURE study reveals significant global disparities in heart failure incidence and mortality, with hypertension as the leading modifiable risk factor, highlighting the need for targeted prevention and treatment strategies.

Section: CardiologyApr 28, 2026

Bradykinin’s Modest Role in Sacubitril/Valsartan’s Blood Pressure Effects Revealed

Bradykinin’s Modest Role in Sacubitril/Valsartan’s Blood Pressure Effects Revealed

A study finds bradykinin modestly contributes to blood pressure reduction with sacubitril/valsartan in chronic heart failure, highlighting ANP’s role in initial effects and bradykinin’s influence during chronic therapy.

Section: CardiologyApr 24, 2026

Left Bundle Branch Pacing Outperforms Traditional Pacing in High-Risk Cardiac Patients

Left Bundle Branch Pacing Outperforms Traditional Pacing in High-Risk Cardiac Patients

A randomized trial shows left bundle branch pacing significantly reduces the risk of pacing-induced cardiomyopathy and improves cardiac function compared to right ventricular pacing in high-risk patients.

Section: CardiologyApr 24, 2026

Right Ventricular to Pulmonary Artery Coupling: A New Prognostic Marker in Heart Failure Therapy

Right Ventricular to Pulmonary Artery Coupling: A New Prognostic Marker in Heart Failure Therapy

A study reveals that RV-PA coupling, measured by TAPSE/sPAP ratio, significantly predicts outcomes in HFrEF patients during GDMT up-titration, highlighting its potential as a treatment target.

Section: CardiologyApr 22, 2026

Biventricular Pacing Outperforms Conduction System Pacing in Heart Failure: Key Insights from PhysioSync-HF Trial

Biventricular Pacing Outperforms Conduction System Pacing in Heart Failure: Key Insights from PhysioSync-HF Trial

PhysioSync-HF trial reveals CSP is inferior to BiVP for HFrEF patients with LBBB, challenging its role as a first-line resynchronization therapy despite cost benefits.

Section: CardiologyApr 22, 2026

LBBP Outperforms BiVP: 74% Reduction in Death or Heart Failure Hospitalization at 3 Years

LBBP Outperforms BiVP: 74% Reduction in Death or Heart Failure Hospitalization at 3 Years

The HeartSync-LBBP trial reveals left bundle-branch pacing reduces the composite of death or heart failure hospitalization by 74% compared to biventricular pacing, with significantly higher super-response rates in patients with reduced ejec

Section: CardiologyApr 18, 2026

Persistent Fibroblast Activation Predicts Heart Failure Progression: [68Ga]FAPI-46 PET/MRI Reveals Distinct Patterns in Ischemic and Nonischemic Cardiomyopathy

Persistent Fibroblast Activation Predicts Heart Failure Progression: [68Ga]FAPI-46 PET/MRI Reveals Distinct Patterns in Ischemic and Nonischemic Cardiomyopathy

A prospective case-control study demonstrates that myocardial fibroblast activation persists in heart failure patients and follows distinct spatial patterns depending on etiology. Using [68Ga]FAPI-46 PET/MRI, researchers found that higher b

Section: CardiologyApr 15, 2026

Exercise Unmasks Multi-Organ Deficits That Predict Heart Failure Risk: Metabolite Signatures Reveal Shared Pathways Across HFpEF and Its Comorbidities

Exercise Unmasks Multi-Organ Deficits That Predict Heart Failure Risk: Metabolite Signatures Reveal Shared Pathways Across HFpEF and Its Comorbidities

A landmark study reveals that exercise-induced multi-organ physiologic deficits strongly predict incident heart failure with preserved ejection fraction (HFpEF). Using invasive cardiopulmonary testing, metabolomics, and genomics across over

Section: CardiologyApr 15, 2026

LBBP Matches BiVP in ECG Metrics but Excels at Cellular Level: Canine Study Redefines Cardiac Resynchronization Therapy

LBBP Matches BiVP in ECG Metrics but Excels at Cellular Level: Canine Study Redefines Cardiac Resynchronization Therapy

A canine study reveals left bundle branch pacing achieves equivalent QRS narrowing and ejection fraction improvement as biventricular pacing, yet demonstrates superior recovery of cardiac mechanics, calcium handling, and energy metabolism a

Section: CardiologyApr 7, 2026

Decoding the Heart Failure Peptidome: A Cross-Sectional Study Uncovers Novel Biomarkers and Patient Clusters

Decoding the Heart Failure Peptidome: A Cross-Sectional Study Uncovers Novel Biomarkers and Patient Clusters

A groundbreaking mass spectrometry study analyzing 486 heart failure patients and 98 controls identified over 21,000 unique peptides, revealing 1,924 differentially expressed peptides. The research highlights angiotensin-related peptides, n

Section: CardiologyApr 5, 2026

Only 1 in 5 Veterans with Heart Failure Achieve Recommended Quadruple Therapy Within 3 Years—What This Means for Clinical Practice

Only 1 in 5 Veterans with Heart Failure Achieve Recommended Quadruple Therapy Within 3 Years—What This Means for Clinical Practice

A large retrospective study of 52,850 veterans reveals that just 21.2% achieve guideline-directed quadruple therapy for HFrEF, with a median time of 197 days. Socioeconomic barriers, including prescription copays, emerge as critical modifia

Section: CardiologyApr 5, 2026

Mid-Regional Pro-Adrenomedullin (MR-proADM): A Superior Prognostic Sentinel in Transthyretin Cardiac Amyloidosis

Mid-Regional Pro-Adrenomedullin (MR-proADM): A Superior Prognostic Sentinel in Transthyretin Cardiac Amyloidosis

This review synthesizes recent evidence identifying MR-proADM as a premier prognostic biomarker in ATTR-CM, demonstrating its ability to outperform traditional natriuretic peptides and enhance existing clinical staging systems.

Section: CardiologyApr 3, 2026

TEER vs. Medical Therapy: Redefining the Management of Atrial Functional Mitral Regurgitation

TEER vs. Medical Therapy: Redefining the Management of Atrial Functional Mitral Regurgitation

A large-scale registry analysis demonstrates that Transcatheter Edge-to-Edge Repair (TEER) significantly reduces mortality and heart failure hospitalizations in patients with atrial functional mitral regurgitation (AFMR) compared to medical

Section: CardiologyMar 28, 2026

Decoding the Diabetic Heart: Five Unique Proteomic Markers Unveil Heart Failure Risk in Patients with Diabetes

Decoding the Diabetic Heart: Five Unique Proteomic Markers Unveil Heart Failure Risk in Patients with Diabetes

Researchers from the ARIC study have identified five specific proteomic markers that uniquely predict heart failure risk in individuals with diabetes. These findings, including four novel proteins, suggest distinct pathophysiological pathwa

Section: CardiologyMar 26, 2026

Navigating the AfMR Maze: Expert Consensus and the Future of Mitral Regurgitation Diagnosis

Navigating the AfMR Maze: Expert Consensus and the Future of Mitral Regurgitation Diagnosis

This article examines the debate between JACC and ESC definitions for Atrial Functional Mitral Regurgitation (AfMR), highlighting why the JACC Expert Consensus offers a more robust framework for clinical prognosis and patient classification

Section: CardiologyMar 26, 2026

Decoding the Diabetic Heart: Novel Proteomic Signatures of Heart Failure Risk in the ARIC Study

Decoding the Diabetic Heart: Novel Proteomic Signatures of Heart Failure Risk in the ARIC Study

A comprehensive review of the ARIC study’s identification of five unique proteomic markers—four novel—that specifically predict heart failure risk in patients with diabetes, offering new insights into lipid metabolism and inflammatory pathw

Section: CardiologyMar 23, 2026

Redefining Risk in Diabetic Kidney Disease: The 2022 AHA/ACC/HFSA Heart Failure Staging and the Efficacy of Sotagliflozin

Redefining Risk in Diabetic Kidney Disease: The 2022 AHA/ACC/HFSA Heart Failure Staging and the Efficacy of Sotagliflozin

This review analyzes the prognostic value of the 2022 Heart Failure staging in patients with diabetes and kidney disease, highlighting the high risk of asymptomatic ‘Pre-HF’ and the consistent therapeutic benefits of sotagliflozin across al

Section: Clinical UpdatesMar 20, 2026

Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis

Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis

This article explores a major international study of 156 acute eosinophilic myocarditis patients, revealing high mortality rates, the diagnostic necessity of endomyocardial biopsy, and the critical survival benefit of early immunosuppressiv

Section: CardiologyMar 20, 2026

Prev 1 2 3 4 8 Next